Clearmind Medicine Inc. Profit Loss
Clearmind Medicine Inc. (CMND) reported Profit Loss of -$3.85 million for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Income Statement
ifrs-full:ProfitLoss · last filed 2026-03-12
- Clearmind Medicine Inc. profit loss for the quarter ending 2023-01-31 was -2.46M CAD.
- Clearmind Medicine Inc. profit loss for the quarter ending 2022-01-31 was -2.09M CAD.
CAD
| Period end | Profit Loss 3 month | Profit Loss 12 month |
|---|---|---|
| 2023-01-31 | -2.46M CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | -9.41M CAD 20-F · filed 2023-02-06 | |
| 2022-01-31 | -2.09M CAD 6-K · filed 2023-03-17 | |
| 2021-10-31 | -3.72M CAD 20-F · filed 2023-02-06 | |
| 2020-10-31 | -412.91K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Profit Loss 3 month | Profit Loss 6 month | Profit Loss 9 month | Profit Loss 12 month |
|---|---|---|---|---|
| 2026-01-31 | -$3.85M 6-K · filed 2026-03-12 | -$4.54M derived: sum of 2 quarters · filed 2026-03-12 | -$5.86M derived: sum of 3 quarters · filed 2026-03-12 | -$6.64M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-10-31 | -$687.84K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$2.00M derived: sum of 2 quarters · filed 2026-01-20 | -$2.79M derived: sum of 3 quarters · filed 2026-01-20 | -$3.86M 20-F · filed 2026-01-20 |
| 2025-07-31 | -$1.31M derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | -$2.10M derived: sum of 2 quarters · filed 2025-09-11 | -$3.17M 6-K · filed 2025-09-11 | -$4.05M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | -$783.93K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | -$1.86M 6-K · filed 2025-06-12 | -$2.74M derived: sum of 3 quarters · filed 2026-03-12 | -$4.83M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-01-31 | -$1.07M 6-K · filed 2026-03-12 | -$1.96M derived: sum of 2 quarters · filed 2026-03-12 | -$4.05M derived: sum of 3 quarters · filed 2026-03-12 | -$4.96M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | -$884.74K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$2.98M derived: sum of 2 quarters · filed 2026-01-20 | -$3.89M derived: sum of 3 quarters · filed 2026-01-20 | -$5.25M 20-F · filed 2026-01-20 |
| 2024-07-31 | -$2.09M 6-K · filed 2024-09-16 | -$3.00M derived: sum of 2 quarters · filed 2024-09-16 | -$4.37M 6-K · filed 2025-09-11 | -$8.44M derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-04-30 | -$908.22K 6-K · filed 2024-06-13 | -$2.28M 6-K · filed 2025-06-12 | -$6.35M derived: sum of 3 quarters · filed 2026-01-20 | -$6.92M derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-01-31 | -$1.37M 6-K · filed 2025-03-13 | -$5.44M derived: sum of 2 quarters · filed 2026-01-20 | -$6.01M derived: sum of 3 quarters · filed 2026-01-20 | -$8.09M derived: sum of 4 quarters · filed 2026-01-20 |
| 2023-10-31 | -$4.07M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$4.64M derived: sum of 2 quarters · filed 2026-01-20 | -$6.72M derived: sum of 3 quarters · filed 2026-01-20 | -$8.62M 20-F · filed 2026-01-20 |
| 2023-07-31 | -$575.19K 6-K · filed 2024-09-16 | -$2.65M derived: sum of 2 quarters · filed 2024-09-16 | -$4.55M 6-K · filed 2024-09-16 | |
| 2023-04-30 | -$2.08M 6-K · filed 2024-06-13 | -$3.98M 6-K · filed 2024-06-13 | ||
| 2023-01-31 | -$1.90M 6-K · filed 2024-03-19 | |||
| 2022-10-31 | -$6.89M 20-F · filed 2025-01-22 | |||
| 2022-04-30 | -$3.86M 6-K · filed 2023-06-14 | |||
| 2021-10-31 | -$2.73M 20-F/A · filed 2024-03-18 |